JP2023505227A5 - - Google Patents
Info
- Publication number
- JP2023505227A5 JP2023505227A5 JP2022533459A JP2022533459A JP2023505227A5 JP 2023505227 A5 JP2023505227 A5 JP 2023505227A5 JP 2022533459 A JP2022533459 A JP 2022533459A JP 2022533459 A JP2022533459 A JP 2022533459A JP 2023505227 A5 JP2023505227 A5 JP 2023505227A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutical composition
- composition according
- crystalline form
- species
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1917867.2 | 2019-12-06 | ||
| GBGB1917867.2A GB201917867D0 (en) | 2019-12-06 | 2019-12-06 | Polymorphs |
| PCT/GB2020/053107 WO2021111142A1 (en) | 2019-12-06 | 2020-12-04 | Polymorphs of triazole antifungal compound pc945 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023505227A JP2023505227A (ja) | 2023-02-08 |
| JP2023505227A5 true JP2023505227A5 (cg-RX-API-DMAC7.html) | 2023-12-13 |
Family
ID=69171938
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022533459A Pending JP2023505227A (ja) | 2019-12-06 | 2020-12-04 | トリアゾール抗真菌化合物pc945の多形 |
Country Status (26)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016087880A1 (en) | 2014-12-05 | 2016-06-09 | Pulmocide Limited | Antimycotic compound |
| CN117510488B (zh) * | 2022-07-28 | 2025-12-05 | 博瑞制药(苏州)有限公司 | 一种硫酸艾沙康唑的制备方法 |
| CN117330660A (zh) * | 2023-09-14 | 2024-01-02 | 广州医科大学附属第一医院(广州呼吸中心) | Uplc-ms/ms联用检测艾沙康唑的方法及应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1292472C (en) | 1985-12-03 | 1991-11-26 | Alfonsus Guilielmus Knaeps | Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles |
| AU2811689A (en) | 1987-11-20 | 1989-06-14 | Schering Corporation | Tri-and tetra-substituted-oxetanes and tetrahydrofurans and intermediates thereof |
| US5039676A (en) | 1990-05-11 | 1991-08-13 | Schering Corporation | Tri- and tetra-substituted-oxetanes and tetrahydrofurans and intermediates thereof |
| DK0736030T3 (da) | 1993-12-21 | 2001-10-29 | Schering Corp | Fungicide tetrahydrofuraner |
| US5714490A (en) | 1993-12-21 | 1998-02-03 | Schering Corporation | Tetrahydrofuran antifungals |
| US5486625A (en) | 1994-07-08 | 1996-01-23 | Schering Corporation | Process for the preparation of chiral intermediates useful for the synthesis of antifungal agents |
| ES2199291T3 (es) | 1995-06-02 | 2004-02-16 | Schering Corporation | Antifungicos de tetrahidrofurano. |
| EP0957101A1 (en) | 1998-05-14 | 1999-11-17 | Janssen Pharmaceutica N.V. | Water soluble azoles as broad-spectrum antifungals |
| PL212985B1 (pl) | 2001-04-03 | 2012-12-31 | Schering Corp | Ciekla zawiesina zawierajaca przeciwgrzybiczo skuteczna ilosc posakonazolu oraz zastosowanie zmikronizowanych czastek posakonazolu |
| EP2141159A1 (en) * | 2008-07-03 | 2010-01-06 | Sandoz AG | A Crystalline form of posaconazole |
| WO2013036866A1 (en) | 2011-09-07 | 2013-03-14 | The Johns Hopkins University | Itraconazole analogs and use thereof |
| WO2016087880A1 (en) * | 2014-12-05 | 2016-06-09 | Pulmocide Limited | Antimycotic compound |
-
2019
- 2019-12-06 GB GBGB1917867.2A patent/GB201917867D0/en not_active Ceased
-
2020
- 2020-12-03 IL IL293401A patent/IL293401B1/en unknown
- 2020-12-04 EP EP20824979.7A patent/EP4069690B1/en active Active
- 2020-12-04 PT PT208249797T patent/PT4069690T/pt unknown
- 2020-12-04 PL PL20824979.7T patent/PL4069690T3/pl unknown
- 2020-12-04 CA CA3155829A patent/CA3155829A1/en active Pending
- 2020-12-04 EP EP24212504.5A patent/EP4509179A3/en active Pending
- 2020-12-04 FI FIEP20824979.7T patent/FI4069690T3/fi active
- 2020-12-04 HU HUE20824979A patent/HUE069799T2/hu unknown
- 2020-12-04 WO PCT/GB2020/053107 patent/WO2021111142A1/en not_active Ceased
- 2020-12-04 JP JP2022533459A patent/JP2023505227A/ja active Pending
- 2020-12-04 US US17/782,232 patent/US12491182B2/en active Active
- 2020-12-04 SM SM20240514T patent/SMT202400514T1/it unknown
- 2020-12-04 CN CN202080082529.6A patent/CN114746415B/zh active Active
- 2020-12-04 AU AU2020397613A patent/AU2020397613A1/en active Pending
- 2020-12-04 HR HRP20250042TT patent/HRP20250042T1/hr unknown
- 2020-12-04 ES ES20824979T patent/ES3000984T3/es active Active
- 2020-12-04 KR KR1020227012753A patent/KR20220110726A/ko active Pending
- 2020-12-04 BR BR112022006259A patent/BR112022006259A2/pt unknown
- 2020-12-04 MX MX2022006654A patent/MX2022006654A/es unknown
- 2020-12-04 RS RS20250045A patent/RS66401B1/sr unknown
- 2020-12-04 LT LTEPPCT/GB2020/053107T patent/LT4069690T/lt unknown
- 2020-12-04 SI SI202030565T patent/SI4069690T1/sl unknown
- 2020-12-04 DK DK20824979.7T patent/DK4069690T3/da active
-
2022
- 2022-06-01 CO CONC2022/0007808A patent/CO2022007808A2/es unknown
- 2022-06-02 CL CL2022001464A patent/CL2022001464A1/es unknown
- 2022-06-05 SA SA522432879A patent/SA522432879B1/ar unknown
-
2025
- 2025-10-15 US US19/359,464 patent/US20260060980A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017536382A5 (cg-RX-API-DMAC7.html) | ||
| US6407129B1 (en) | Azole compounds, their production and their use | |
| JP2011500779A5 (cg-RX-API-DMAC7.html) | ||
| FI4069690T3 (fi) | Triatsolisienilääkeyhdiste pc945:n polymorfeja | |
| JP2017536385A5 (cg-RX-API-DMAC7.html) | ||
| KR101639456B1 (ko) | 포사코나졸의 결정질 형태 | |
| CN107001343B (zh) | 抗真菌的化合物 | |
| EP1511490A2 (en) | Novel conazole crystalline forms and related processes, pharmaceutical compositions and methods | |
| JP5635075B2 (ja) | 抗真菌医薬組成物 | |
| JP2017536371A5 (cg-RX-API-DMAC7.html) | ||
| US20050070551A1 (en) | Novel crystalline forms of conazoles and methods of making and using the same | |
| US4782059A (en) | Method of controlling mycotic infections and compositions therefor | |
| WO2018073839A1 (en) | Amorphous osimertinib mesylate, processes for its preparation and solid amorphous dispersions thereof | |
| JPH11504931A (ja) | 抗真菌組成物 | |
| US20090088443A1 (en) | Novel crystalline forms of conazoles and methods of making and using the same | |
| EP2255785A2 (en) | Stable emulsion composition | |
| US20080032994A1 (en) | Modified azole compounds as antifungal and antibacterial agents | |
| US20070293674A1 (en) | Novel Saperconazole Crystalline Forms and Related Processes, Pharmaceutical Compositions and Methods | |
| EP2027850A1 (en) | Pharmaceutical compositions containing voriconazole | |
| EP1120116A1 (en) | Antimycotic drug composition | |
| BRPI9811679B1 (pt) | antifúngicos de 1-{4-[4-(4-{[4-fenil-4-(1 h-1,2,4-triazol-1-ilmetil)-1,3-dioxolan-2-il]metóxi}fenil)piperazin-1-il]fenil}imidazolidin-2-onas substituídas | |
| HUP0200872A2 (hu) | Antifungális hatású éterek, eljárás az előállításukra, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk | |
| EA048470B1 (ru) | Полиморфы триазольного противогрибкового соединения pc945 | |
| WO2019106571A1 (en) | Dosing regimens for the treatment of fungal infections | |
| EP1718640A1 (en) | Novel crystalline forms of conazoles and methods of making and using the same |